U.S. Implants of Eyeonics CrystalensΠSurpass 13,000 During First Year on the Market

January 18, 2005 Posted by Eyeonics, Inc


First and Only FDA Approved Accommodating IOL Now Implanted in More Than 20,000 Eyes Worldwide

Eyeonics, inc.(TM), the developer of the crystalens, the first and only FDA approved accommodating intraocular lens, announced on 18 January 2005 that more than 13,000 crystalens were implanted in the U.S. during the company’s first year in the U.S. market. "Demand for the crystalens by ophthalmologists and their patients has been much higher than anticipated," commented J. Andy Corley, Chairman and CEO of eyeonics. "As a result of this demand we tripled the number of employees in the field during 2004, and we will continue to increase our field personnel in 2005. The 13,000 implants in the U.S. during our first year have provided doctors a new source of revenue due to the unique and superior solution offered by the crystalens," said Corley. Dr. Harvey Carter, a prominent ophthalmologist in Dallas, Texas, and one of the world’s leading crystalens implanters, having implanted more than 500 crystalens, commented, "Integrating the crystalens into my practice has significantly increased surgical revenue, and, more importantly, has given my private patients the best technology option for rejuvenating their vision. My patients with crystalens often comment that they’ve never seen better." The crystalens, which is the result of more than 14 years of research and development by J. Stuart Cumming, M.D., F.A.C.S., Chief Scientific Officer of eyeonics, received FDA approval in November 2003. During the clinical trial, all of the patients who received the crystalens greatly reduced their need for corrective lenses or glasses. The patented crystalens technology is designed to allow the lens to move in the eye in a manner similar to the natural lens. By using the eye’s muscle to move the lens backwards and forwards naturally, patients can focus through a continuous range of vision including near, far and intermediate vision. All other intraocular lenses are designed to remain fixed in the eye.

Leave a comment:

Commenting is not available in this weblog entry.